BioHealth News Archive

Johns Hopkins-based startup Baton among participants in DreamIT Health Baltimore accelerator | Hub

Johns Hopkins-based startup Baton among participants in DreamIT Health Baltimore accelerator | Hub

For the second consecutive year, Johns Hopkins University and Johns Hopkins Medicine are co-sponsors of DreamIt Health Baltimore, a four-month boot camp for entrepreneurs…

Read More
Converge AT ALEXANDRIA – Exploring Autism – April 2, 2015

Converge AT ALEXANDRIA – Exploring Autism – April 2, 2015

THURSDAY, APRIL 2, 2015 | 4:30 – 7:00 PM ALEXANDRIA CENTER® FOR LIFE SCIENCE – NEW YORK CITY Converge at Alexandria is a quarterly…

Read More
“Filtering Through the Noise in the Heath IT Revenue Spectrum: What Works and What Doesn’t?”- The Society of Physician Entrepreneurs

“Filtering Through the Noise in the Heath IT Revenue Spectrum: What Works and What Doesn’t?”- The Society of Physician Entrepreneurs

Wednesday, April 1st, 2015--6:00PM to 8:00PM With all of the focus on patient engagement, physician adoption, increased accessibility, lowering costs, improving outcomes and the…

Read More
Emergent BioSolutions produces new Ebola vaccine, teaming with NIH, GlaxoSmithKline – Baltimore Sun

Emergent BioSolutions produces new Ebola vaccine, teaming with NIH, GlaxoSmithKline – Baltimore Sun

At its growing East Baltimore facility, Emergent BioSolutions has produced a booster shot to go with a leading Ebola vaccine candidate, joining a competitive…

Read More
Emergent completes proof-of-concept production of new Ebola vaccine – Pharmaceutical Business Review

Emergent completes proof-of-concept production of new Ebola vaccine – Pharmaceutical Business Review

US-based Emergent BioSolutions has completed proof-of concept manufacturing of a modified vaccinia Ankara (MVA) Ebola Zaire vaccine candidate (MVA EBOZ). The MVA Ebola Zaire…

Read More
Peter Thiel Invests in Anti-Aging Cure – MIT Technology Review

Peter Thiel Invests in Anti-Aging Cure – MIT Technology Review

Peter Thiel is the co-founder of PayPal, the investor who discovered Facebook, and the author of Zero to One, a short account of the…

Read More
Who would win the women’s NCAA tournament if the games were decided by academic performance? @insidehighered

Who would win the women’s NCAA tournament if the games were decided by academic performance? @insidehighered

Welcome to the fourth annual Inside Higher Ed academic bracket for the National Collegiate Athletic Association women's basketball tournament. With this bracket, how teams…

Read More
Gaithersburg’s Emergent BioSolutions manufactures Ebola vaccine candidate for clinical trials with GlaxoSmithKline – Washington Business Journal

Gaithersburg’s Emergent BioSolutions manufactures Ebola vaccine candidate for clinical trials with GlaxoSmithKline – Washington Business Journal

Emergent BioSolutions Inc. has manufactured a possible Ebola vaccine that could serve as the booster for GlaxoSmithKline's frontrunner candidate in the international race to…

Read More
Mayo Clinic Surgeons Investigate Use of Drones for Medicine

Mayo Clinic Surgeons Investigate Use of Drones for Medicine

Commercially available unmanned aerial vehicles (UAVs), commonly known as drones, have gotten pretty amazing and quite cheap over the last few years, thanks to…

Read More
NHLBI Funding & Research Opportunities and Announcements for March 16, 2015

NHLBI Funding & Research Opportunities and Announcements for March 16, 2015

Funding and Research Opportunities The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:…

Read More
Who would win the NCAA tournament if the games were decided by academic performance? @insidehighered

Who would win the NCAA tournament if the games were decided by academic performance? @insidehighered

It's time once again to fill out those March Madness brackets, and what better way to predict the winner of this year's National Collegiate…

Read More
MacroGenics Initiates Phase 1 Study of MGD010 for the Treatment of Autoimmune Disorders Nasdaq:MGNX

MacroGenics Initiates Phase 1 Study of MGD010 for the Treatment of Autoimmune Disorders Nasdaq:MGNX

MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, as well…

Read More
Johns Hopkins gears up for more startups

Johns Hopkins gears up for more startups

Johns Hopkins University is making its move. The institution has been promising — threatening — to be a bigger player in technology commercialization, the…

Read More
5 DC-Area Colleges Ranked Best Universities in the World | DC Inno

5 DC-Area Colleges Ranked Best Universities in the World | DC Inno

The Times Higher Education World University Rankings 2014-2015 list was released Friday, effectively depicting the best universities from across the globe. The D.C. area made a…

Read More
Agenda for Learning from Each Other: U.S. and European Perspectives on SBIR

Agenda for Learning from Each Other: U.S. and European Perspectives on SBIR

Learning from Each Other:  U.S. and European Perspectives on Small Business Innovation Programs   March 19, 2015  Lecture Room National Academy of Sciences 2100…

Read More